Kintara Therapeutics Inc (KTRA)
0.2624
+0.02
(+6.19%)
USD |
NASDAQ |
Jun 24, 16:00
0.2522
-0.01
(-3.89%)
After-Hours: 20:00
Kintara Therapeutics Cash from Financing (Quarterly): 7.993M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 7.993M |
| December 31, 2023 | 2.579M |
| September 30, 2023 | -0.002M |
| June 30, 2023 | -0.002M |
| March 31, 2023 | -0.002M |
| December 31, 2022 | -0.05M |
| September 30, 2022 | 1.906M |
| June 30, 2022 | 7.933M |
| March 31, 2022 | -0.002M |
| December 31, 2021 | -0.171M |
| September 30, 2021 | 13.88M |
| June 30, 2021 | -0.492M |
| March 31, 2021 | 3.198M |
| December 31, 2020 | -0.016M |
| September 30, 2020 | 23.35M |
| June 30, 2020 | -0.003M |
| March 31, 2020 | -0.002M |
| December 31, 2019 | -0.001M |
| September 30, 2019 | 6.607M |
| June 30, 2019 | 3.379M |
| March 31, 2019 | -0.0859M |
| December 31, 2018 | 0.7829M |
| September 30, 2018 | -0.0021M |
| June 30, 2018 | -0.0021M |
| March 31, 2018 | 0.3104M |
| Date | Value |
|---|---|
| December 31, 2017 | -0.0021M |
| September 30, 2017 | 8.943M |
| June 30, 2017 | 7.956M |
| March 31, 2017 | 0.1905M |
| December 31, 2016 | 0.0677M |
| September 30, 2016 | 0.2549M |
| June 30, 2016 | 6.774M |
| March 31, 2016 | -0.0627M |
| December 31, 2015 | 0.4031M |
| September 30, 2015 | 2.452M |
| June 30, 2015 | -0.4436M |
| March 31, 2015 | 0.0273M |
| December 31, 2014 | 0.7365M |
| September 30, 2014 | 0.5276M |
| March 31, 2014 | 0.2218M |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 9.640M |
| December 31, 2012 | 0.005M |
| September 30, 2012 | 0.003M |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.0051M |
| December 31, 2011 | 0.0024M |
| September 30, 2011 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.492M
Minimum
Jun 2021
23.35M
Maximum
Sep 2020
3.504M
Average
-0.0015M
Median
Cash from Financing (Quarterly) Benchmarks
| ARCA biopharma Inc | 0.00 |
| Vanda Pharmaceuticals Inc | -- |
| Asensus Surgical Inc | 0.811M |
| Catalent Inc | 0.00 |
| CEL-SCI Corp | 6.596M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.30M |
| Free Cash Flow | -7.262M |
| Free Cash Flow Per Share (Quarterly) | -0.0516 |
| Free Cash Flow Yield | -211.6% |